Terms: = Prostate cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1 AND Treatment
25 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced prostate cancer.
Pimenta R; Mioshi CM; Gonçalves GL; Candido P; Camargo JA; Guimarães VR; Chiovatto C; Ghazarian V; Romão P; da Silva KS; Dos Santos GA; Silva IA; Srougi M; Nahas WC; Leite KR; Viana NI; Reis ST
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298588
[TBL] [Abstract] [Full Text] [Related]
3. In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia.
Choi YJ; Fan M; Tang Y; Yang HP; Hwang JY; Kim EK
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615010
[TBL] [Abstract] [Full Text] [Related]
4. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.
Zhang Y; Shi W
Biochem Cell Biol; 2019 Aug; 97(4):488-496. PubMed ID: 30532986
[TBL] [Abstract] [Full Text] [Related]
5. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in prostate cancer.
Culig Z
J Cell Physiol; 2016 Feb; 231(2):270-4. PubMed ID: 26201947
[TBL] [Abstract] [Full Text] [Related]
6. LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.
Tints K; Prink M; Neuman T; Palm K
Int J Mol Sci; 2014 Apr; 15(4):5680-98. PubMed ID: 24705462
[TBL] [Abstract] [Full Text] [Related]
7. Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.
Zhang Y; Wang JH; Liu B; Qu PB
Asian Pac J Cancer Prev; 2013; 14(6):3847-50. PubMed ID: 23886194
[TBL] [Abstract] [Full Text] [Related]
8. APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.
Chen Y; Li J; Yu X; Li S; Zhang X; Mo Z; Hu Y
Eur J Hum Genet; 2013 Sep; 21(9):929-35. PubMed ID: 23299921
[TBL] [Abstract] [Full Text] [Related]
9. cancer in Kashmir, India: burden and pattern of disease.
Rasool MT; Lone MM; Wani ML; Afroz F; Zaffar S; Mohib-ul Haq M
J Cancer Res Ther; 2012; 8(2):243-6. PubMed ID: 22842369
[TBL] [Abstract] [Full Text] [Related]
10. Cost minimisation analysis: kilovoltage imaging with automated repositioning versus electronic portal imaging in image-guided radiotherapy for prostate cancer.
Gill S; Younie S; Rolfo A; Thomas J; Siva S; Fox C; Kron T; Phillips D; Tai KH; Foroudi F
Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):e93-9. PubMed ID: 22694787
[TBL] [Abstract] [Full Text] [Related]
11. [Inhibition of SRC-1 expression in prostate cancer cells by RNAi and its significance].
Peng B; Wang SQ; Zhao HJ; Weng ZL
Zhonghua Nan Ke Xue; 2011 Sep; 17(9):805-8. PubMed ID: 21961241
[TBL] [Abstract] [Full Text] [Related]
12. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
[TBL] [Abstract] [Full Text] [Related]
13. Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells.
Wang XL; Kong F; Shen T; Young CY; Lou HX; Yuan HQ
Acta Pharmacol Sin; 2011 Mar; 32(3):338-44. PubMed ID: 21372825
[TBL] [Abstract] [Full Text] [Related]
14. Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.
Zhang Z; Kovalenko P; Cui M; Desmet M; Clinton SK; Fleet JC
J Cell Physiol; 2010 Aug; 224(2):433-42. PubMed ID: 20432439
[TBL] [Abstract] [Full Text] [Related]
15. Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activity.
Kollara A; Brown TJ
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):51-8. PubMed ID: 19815066
[TBL] [Abstract] [Full Text] [Related]
16. Androgen axis in prostate cancer.
Culig Z; Bartsch G
J Cell Biochem; 2006 Oct; 99(2):373-81. PubMed ID: 16598769
[TBL] [Abstract] [Full Text] [Related]
17. Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours.
Culig Z; Steiner H; Bartsch G; Hobisch A
Endocr Relat Cancer; 2005 Jun; 12(2):229-44. PubMed ID: 15947099
[TBL] [Abstract] [Full Text] [Related]
18. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
[TBL] [Abstract] [Full Text] [Related]
19. Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment.
Thin TH; Wang L; Kim E; Collins LL; Basavappa R; Chang C
J Biol Chem; 2003 Feb; 278(9):7699-708. PubMed ID: 12499384
[TBL] [Abstract] [Full Text] [Related]
20. Androgen receptors in prostate cancer.
Culig Z; Klocker H; Bartsch G; Hobisch A
Endocr Relat Cancer; 2002 Sep; 9(3):155-70. PubMed ID: 12237244
[TBL] [Abstract] [Full Text] [Related]
[Next]
